InvestorsHub Logo

ahab333

11/18/19 1:35 PM

#1190 RE: abracky #1189

Abracky, I like what I read on SciStar improvements to those cohorts. Looks to be continuing progression for those in the 1/2b open label trials. I wonder how much longer will or if both sides reflect the same improvements? GLTU and thanks for sharing this PR from LCTX/BTX converted symbol

HCIT